Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Lyka Labs, an Indian drug company, has signed a technology transfer agreement with Turkish pharmaceutical company to deploy their manufacturing process that would involve a cost of $2,50,000 besides royalty payments over the upcoming five years.
Subscribe to our email newsletter
The manufacturing practices are believed to help in longer storage of medicines, The Hindu reported.
The news agency quoted Lyka Labs saying to Bombay Stock Exchange that they have signed a technology transfer pact with the Turkish firm for a lyophilized formulation.
Lyophilization is believed to be a manufacturing process which enables longer storage of pharmaceuticals and causes no degradation in materials.